Summary
Aware Inc. posted lower profit in the fiscal 2017 third quarter. Revenue was $5.7 million for the three months ended September 30, 2017 and $12.4 million for the nine months ended September 30, 2017. Operating income fell 28.0% to $1.66 million from $2.31 million in the prior-year quarter. Net income dropped 21.9% to $1.23 million from $1.57 million. Diluted earnings per share were $0.06, down from $0.07. Operating margin was 29.2% for the quarter and 18.4% for the nine month period.
Revenue held close to the year-ago level, so the profit decline came from expenses and from a smaller patent payout. The mix moved toward licenses. Software license revenue rose 7% to $4.4 million from $4.1 million and made up 75% of total revenue, up from 70%. Imaging licenses reached $2.5 million against $1.3 million, lifted by a medical imaging customer agreement signed in the third quarter. Biometrics licenses fell to $1.9 million from $2.8 million because the prior-year quarter contained a large system integrator sale with no match this year. Maintenance revenue declined 15% to $1.1 million from $1.3 million, and services revenue declined 19% to $0.3 million from $0.4 million. There were no hardware sales in either quarter. Royalties slipped 17% to $41,000 from $49,000.
The nine month figures show the bigger break. Software license revenue fell 32% to $8.3 million from $12.3 million. Biometrics licenses dropped to $5.4 million from $8.2 million, with USMC and Navy software sales of $1.1 million against $3.8 million a year earlier. Imaging licenses were $3.0 million versus $4.0 million. Maintenance revenue declined 3% to $3.6 million from $3.7 million. Services fell 13% to $0.9 million from $1.1 million. Hardware revenue dropped 100% to zero from $317,000. Royalties were $118,000, down 53% from $252,000. Operating income for the nine months fell 56.6% to $2.29 million from $5.27 million. Net income declined 48.9% to $1.86 million from $3.64 million, and diluted EPS was $0.08 against $0.16.
Expenses pushed against the top line. Research and development expense rose 23% to $2.2 million from $1.8 million, mostly for a third party development firm working on a new product. That work finished in the third quarter and management states that no further third party expense is coming. Selling and marketing expense edged down 1% to $1.05 million, and general and administrative expense slipped 1% to $849,000. Cost of services rose 23% to $178,000 from $146,000 on the mix of projects in services revenue. Cost of software licenses was $27,000 against zero a year ago after third party software shipped to the Navy. Patent related income was $19,000 in the quarter and $1.4 million for the nine months, compared with $238,000 in each year-ago period.
Cash generation weakened along with profit. Operating cash flow was $0.34 million in the quarter, down 79.6% from $1.68 million, and $0.61 million for the nine months, down 77.3% from $2.69 million. Capital expenditures were $8,000 in the quarter versus $28,000, and $61,000 for the nine months versus $82,000. Cash and cash equivalents totaled $49.1 million at September 30, 2017, a decrease of $2.8 million from December 31, 2016. The company used $4.2 million to buy back stock in the first nine months. Deferred revenue was $2.73 million at quarter end.
The outlook in the 10-Q is qualitative rather than a set of numeric targets, and it leans cautious. Management says it cannot predict whether the USMC or the Navy will buy software again, and it cannot predict how much more patent arrangement income may arrive. DSL royalties are expected to keep declining. Services backlog was minimal at September 30, 2017, which management says makes a return to 2014 and 2015 services levels unlikely without new projects. Hardware backlog was zero and growing hardware revenue is not part of the strategy. The IRS began an examination of the company's 2015 tax return in the second quarter of 2017. Aware carries $5.6 million of deferred tax assets with no valuation allowance, a position that rests on expected future earnings.
Forecast
Reported figures
GAAP, from SEC filings| Metric | Q3 FY2017 | Q2 FY2017 | QoQ | Q3 FY2016 | YoY |
|---|---|---|---|---|---|
| Revenue | $343.0K | $206.0K | +66.5% | $426.0K | -19.5% |
| Gross profit | $165.0K | $102.0K | +61.8% | $280.0K | -41.1% |
| Gross margin | 48.1% | 49.5% | -1.4 pp | 65.7% | -17.6 pp |
| Research & development | $2.2M | $1.9M | +14.7% | $1.8M | +22.8% |
| Sales & marketing | $1.1M | $1.0M | +2.9% | $1.1M | -1.4% |
| General & administrative | $849.0K | $816.0K | +4.0% | $857.0K | -0.9% |
| Total operating expenses | $4.3M | $3.8M | +11.5% | $3.8M | +11.4% |
| Operating income (loss) | $1.7M | $238.0K | +599.6% | $2.3M | -28.0% |
| Operating margin | 485.4% | 115.5% | +369.9 pp | 543.0% | -57.5 pp |
| Net income (loss) | $1.2M | $228.0K | +439.0% | $1.6M | -21.9% |
| Net margin | 358.3% | 110.7% | +247.6 pp | 369.3% | -10.9 pp |
| Diluted EPS | $0.06 | $0.01 | +$0.05 | $0.07 | -$0.01 |
Risks
Revenue depends on large U.S. government biometrics programs, and MD&A states software sales to the U.S. Marine Corps and U.S. Navy were lower in the first nine months of 2017 versus the prior-year period. The company cannot predict whether those customers will purchase the software again.
Operating income decreased 28.0% in the quarter and 56.6% year to date, per reported figures. MD&A attributes the decline partly to higher operating expenses and lower income from a patent arrangement.
Imaging software license revenue in the third quarter of 2017 benefited from a new medical imaging customer agreement, while the prior-year period included a systems integrator arrangement that had no remaining revenue to recognize in 2017, making license revenue lumpy.
Services backlog was minimal as of September 30, 2017, and MD&A states services revenue is unlikely to return to 2014 and 2015 levels unless new service projects are obtained.
MD&A reports no hardware orders in backlog as of September 30, 2017 and believes future Navy hardware orders may be minimal. Hardware is not part of the company's growth strategy.
MD&A reports income from a patent monetization arrangement in the first nine months of 2017, but says it cannot predict how much more income, if any, will be received because success of the third party's monetization efforts is uncertain.
Operating cash flow decreased 79.6% in the quarter and 77.3% year to date, per reported figures, driven by lower operating results and changes in assets and liabilities.
MD&A says the company is expanding into new commercial biometrics markets, but these are emerging markets and future revenue from them cannot be predicted.
The company has significant deferred tax assets with no valuation allowance and will continue to assess realizability. The IRS commenced an examination of the company's 2015 tax return in the second quarter of 2017.
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q3 FY2017 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Nov 9, 2026.